Huntington’s Disease

Huntington’s Disease

Study-related travel may be provided at no cost to many study participants and their study partner including flights, ground transportation, lodging, and meals for both the patient and caregiver. Travel arrangements and reimbursements may vary from study to study.

Huntington’s Disease Society of America Designated Center of Excellence

The multidisciplinary Huntington’s disease clinic offers access to a variety of services all in one Center and in one clinical visit:

  • Neurology
  • Clinical Psychology
  • Genetic Counseling
  • Social Work
  • Occupational Therapy
  • Physical Therapy
  • Speech Therapy

At world-class facilities such as ours, “patients benefit from expert neurologists, psychiatrists, therapists, counselors and other professionals who have deep experience working with families affected by Huntington’s Disease and who work collaboratively to help families plan the best Huntington’s Disease care program throughout the course of the disease.” -HDSA

Genetic Testing & Counseling

Tremendous HD Advances:

The scientific community has made tremendous advances in Huntington’s disease research and we are beginning to study new experimental medications which have the potential to slow the progression of Huntington’s disease. Preliminary data based on animal models of Huntington’s disease suggests that potentially disease slowing treatments might be most effective if applied early in the disease. It is not certain that these investigational medications will work in people and so clinical trials in humans with Huntington’s disease are needed to demonstrate that these interventions are indeed safe and effective.

Reasons to Test

Reasons for some patients to consider pre-symptomatic genetic testing include the following: 1. Information to best allow Life planning purposes to decide about future career or other life decisions; 2. for family planning purposes to determine whether or not once children may be at risk of developing Huntington’s disease; 3. For psychological reasons since living with the uncertainty of whether or not one is going to develop Huntington’s disease may be extremely stressful for many patients; 4. To allow one to be proactive in taking advantage of the ability to participate in research studies that may slow the progression of Huntington’s disease.

Learn about Clinical Trials

We are currently enrolling Huntington’s disease patients in an observational and clinical trial.

Pre-symptomatic genetic testing may be considered by patients who have a family history of Huntington’s disease who wish to know if they will definitely develop Huntington’s disease. The decision to obtain this information is often a difficult one and patients need to be psychologically prepared to receive this information. We work with each individual considering presymptomatic genetic testing to help determine whether or not they are prepared to undergo this process and received this information. Patients who are considering recent genetic testing are first interviewed by our social worker who obtains basic information about the patient, any clinical symptoms that may be worrisome for Huntington’s disease, and information about the patient’s family history of Huntington’s disease. Information about the pre-symptomatic testing protocol provided in significant detail to patients at this time.

Space in this study is limited.
To be considered, please fill out the form or call 720-776-0092.


No cost studies are currently available for qualified participants.


No health insurance required


Compensation for time and travel TBD



Male / Female



701 E Hampden Ave, Ste 510
Englewood, CO 80113

State-of-the-Art Facilities

CenExel RMCR is Colorado's premier clinical research organization. For over 15 years, we’ve helped improve the quality of life for everyone by researching new medications and treatments. Our state-of-the-art facility is held to the highest standards of cleanliness and quality.

Board-Certified Physician

Your safety is our greatest concern. Every study at CenExel RMCR is overseen by expert medical staff and one of the most well-respected, board-certified physicians in the clinical research industry with 25+ years of experience.

FDA-Approved Procedures

Rest assured, you are not signing up for treatment with “experimental” methods. RMCR only uses FDA approved methods as if you were at any other hospital or clinic. Our research is focused on the medication associated with those methods.

Frequently asked questions

What is a CenExel Center of Excellence?

CenExel Centers of Excellence provide unparalleled medical and scientific support in the design and execution of clinical trials. Their attention to detail assures quality, reliable results and has helped CenExel to consistently achieve and exceed patient recruitment goals. They have conducted thousands of studies, the variety and complexity of which have resulted in a great depth of experience and insight for the principal investigators and research staff in each facility. CenExel Centers of Excellence deliver the engagement, expertise, and results to ensure that clients achieve their clinical research goals.

How do clinical trials work?

The study procedures and process will vary depending on the type of clinical trial you participate in. Before you begin a study, the process and all procedures for that study will be explained to you. Throughout the study, the Study Coordinator and the Principal Investigator will assist you and can answer any questions you have. They will check your health at the beginning of the trial, give you specific instructions for participating in the trial, monitor you carefully during the trial, and stay in touch with you after the study.

Some clinical trials involve more tests and doctor visits than you would normally have for your illness or condition. Your participation will be most successful if you carefully follow all instructions you are given and stay in contact with the research staff.

How safe are clinical studies?

There are many safeguards in place that all companies must follow when conducting clinical trials.

The Food and Drug Administration (FDA) is the regulatory agency that oversees all clinical research conducted in the United States. It is their responsible to protect the rights and as much as possible, the welfare of subjects participating in clinical trials. They ensure that data collected from clinical trials is of the highest quality and they are the agency that determines whether a new treatment should be sold in the US. Several organizations and individuals are governed by FDA regulations including clinical investigators, sponsors (the companies developing the treatments), Contract Research Organizations (companies that help conduct the studies), and Institutional Review Boards (groups that are responsible for ensuring the safety and welfare of study participants).

Good Clinical Practice (GCP) guidelines are another safeguard implemented to protect the safety of subjects. These guidelines encompass federal regulations and industry-accepted standards that govern clinical trials on humans. These regulations and standards apply to the conduct of the studies, record keeping, informed consent of subjects, collection of scientific data, and submission of information needed for the FDA to determine whether a new treatment should or should not be sold in the US. All companies must follow these guidelines when conducting clinical research.

An Institutional Review Board (IRB) is a committee that is formally tasked by an institution to review, approve, and monitor research involving human subjects. IRBs ensure that the risks to subjects are minimized; that subjects are adequately informed about the trial and the implications it will have on their treatment; that study protocols are modified, when necessary, to ensure safety; that risks are reasonable in relation to the anticipated benefits and the importance of the knowledge to be gained; that subject selection is equitable and that no classes of patients are discriminated against; that informed consent is obtained; that there is a provision for safety monitoring in the research plan; and that here are adequate provisions for the privacy and confidentiality for subjects and the data collected.

Translate »